WTKR

FDA approves first Symbicort generic drug for asthma and COPD

The U.S. Food and Drug Administration on Tuesday approved the first generic Symbicort drug used to treat asthma and chronic obstructive pulmonary disease (COPD), which are two common pulmonary health ...
clinicaladvisor.com

N-Acetylcysteine Nebulizer for COPD is Effective, Safe for Phlegm Treatment

After 12 weeks of nebulized NAC, patients’ mean phlegm scores, as measured by the COPD assessment test, significantly decreased from 3.47 at baseline to 2.62. N-acetylcysteine (NAC) nebulizer therapy ...
FierceBiotech

GSK, Theravance hit up regulators for approval of key asthma/COPD drug

In Europe, however, the companies want nods for both the COPD and asthma indications right off the bat, seeking to market the drug in Europe as Relvar. - here's the release - see Reuters ' brief Let ...
Medical Xpress

First new treatment for asthma and COPD in half a century—new study

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms. For decades, the standard treatment for these potentially ...
Healthline

Dosage Details for Perforomist (Formoterol)

The usual Perforomist dosage for COPD is one treatment with a nebulizer twice per day. Specific dosages may vary depending on factors such as other medications you may be taking. It’s important to use ...